Wolverine Asset Management LLC Repligen Corp Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $107,902 - $179,612	-554 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $8,956 - $11,931	54 Added 10.8%	554 $110,000
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $61,255 - $79,135	500 New	500 $73,000
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $180,299 - $257,335	-3,736 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $294,840 - $371,511	-6,300 Reduced 62.77%	3,736 $207,000
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $353,869 - $472,093	10,036 New	10,036 $472,000

481

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.82B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.